180 Life Sciences Corp. (ATNFW) NASDAQ

0.43

-0.03(-6.52%)

Updated at August 15 04:00PM

Currency In USD

180 Life Sciences Corp.

Address

Building 4

Palo Alto, DE 94306

United States of America

Phone

650 507 0669

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Employees

4

First IPO Date

June 27, 2017

Key Executives

NameTitlePayYear Born
Mr. Lloyd Blair Jordan L.L.B., M.B.A.Chief Executive Officer & Director211,9821970
Dr. Lawrence Steinman BA, M.D., Ph.D.Co-Founder & Director30,0001948
Sir Marc Feldman Ph.D.Co-Founder130,0621945
Prof. Jagdeep Nanchahal M.D., Ph.D.Co-Founder & Chairman of Clinical Advisory Board0N/A
Mr. Eric R. Van LentCAO, Principal Accounting & Financial Officer01983

Description

180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palo Alto, CA.